Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, Peritoneal Cancer, or Fallopian Tube Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Antonio Jimeno
Hospital Universitario 12 de Octubre
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
92 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Prince of Wales Private Hospital
Randwick, New South Wales, Australia
- Tamworth Base Hospital
Tamworth, New South Wales, Australia
- Manning Base Hospital
Taree, New South Wales, Australia
- Newcastle Mater Misericordiae Hospital
Waratah, New South Wales, Australia
- Royal Brisbane and Women'S Hospital
Brisbane, Queensland, Australia
- Royal Women'S Hospital
Carlton, Victoria, Australia
- Frankston Hospital
Frankston, Victoria, Australia
- Murray Valley Private Hospital and Cancer Treatment Centre
Wodonga, Victoria, Australia
- Sir Charles Gairdner Hospital - Nedlands
Nedlands, Western Australia, Australia
- Landeskrankenhaus Klagenfurt
Klagenfurt, Austria
- A.O. Bezirkskrankenhaus Kufstein
Kufstein, Austria
- Centre Hospitalier General
Amilly, France
- Centre Hospitalier de L' Agglomeration Montargoise
Amilly, France
- Centre Hospital General Robert Ballanger
Aulnay-sous-Bois, France
- Centre Hospitalier Regional de Besancon - Hopital Jean Minjoz
Besançon, France
- Clinique Tivoli
Bordeaux, France
- Institut Bergonie
Bordeaux, France
- Polyclinique Bordeaux Nord Aquitaine
Boucher, France
- Centre Regional Francois Baclesse
Caen, France
- Centre Hospitalier Regional de Chambery
Chambéry, France
- Centre Jean Perrin
Clermont-Ferrand, France
- Hopital Louis Pasteur
Colmar, France
- Centre Hospitalier de Dax
Dax, France
- Centre Hospitalier de Gap
Gap, France
- Centre Hospitalier Departemental
La Roche-sur-Yon, France
- Clinique Victor Hugo
Le Mans, France
- Centre Hospitalier Bretagne Sud
Lorient, France
- Centre Leon Berard
Lyon, France
- Hopital Saint Joseph
Marseille, France
- Centre Hospitalier General de Mont de Marsan
Mont-de-Marsan, France
- Centre Hospitalier General Andre Boulloche
Montbéliard, France
- Centre Hospitalier de Montlucon
Montluçon, France
- Centre Regional de Lutte Contre Le Cancer - Centre Val D'Aurelle
Montpellier, France
- Hotel Dieu de Paris
Paris, France
- Institut Curie Hopital
Paris, France
- Centre Hospitalier Lyon Sud
Pierre-Bénite, France
- Chu Poitiers
Poitiers, France
- Polyclinique Francheville
Périgueux, France
- Institut Jean Godinot
Reims, France
- Centre Eugene Marquis
Rennes, France
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2005
- Primary completion
- 29 Feb 2008
- Completion
- —
- Last update posted
- 27 Aug 2013
- Registered enrollment
- 835
- Registry id
- NCT00263822
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.